Tirzepatide denied as not medically necessary by Cigna?

Cigna's specific coverage criteria for tirzepatide are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Cigna Denies Tirzepatide on Medical-Necessity Grounds

A medical-necessity denial is Cigna's determination that, based on the clinical information submitted, tirzepatide does not meet the plan's criteria for coverage as medically necessary. This is the most common and most frequently overturned denial type. Cigna's medical-necessity criteria for tirzepatide are set out in its published coverage/medical policy and will reference the FDA-approved prescribing label — both documents define exactly what clinical facts must be documented.

The denial usually occurs because the initial PA submission was incomplete, the chart did not clearly document one or more required criteria, or the clinical reviewer applied a more restrictive standard than the policy actually requires. A well-documented appeal that maps each criterion to a specific chart entry is highly effective.

## Your Federal Appeal Rights

Under ACA §2719 and ERISA §503, you have the right to a full internal review and an independent external review. Internal appeals must typically be filed within 180 days of the denial notice. External review is generally available for approximately 4 months after final internal denial. Request expedited review if clinical deterioration is occurring or imminent.

## Concrete Appeal Steps

1. Obtain the denial letter with the specific medical-necessity criteria cited as unmet. 2. Request Cigna's current coverage/medical policy for tirzepatide by name — it must be provided. 3. Audit the chart against each criterion: identify what is documented and what gaps exist. 4. Have your prescriber address every gap in a detailed medical-necessity letter, referencing specific chart dates and entries. 5. File the internal appeal with the structured clinical package. 6. If denied internally, file for external review.

## Documentation to Gather

• Diagnosis confirmation: chart notes, specialist assessments, relevant diagnostic codes establishing the covered indication
• Objective clinical findings: your own chart values (body weight trends, relevant lab results, comorbidity assessments) — not generic thresholds
• Prior treatment history: chronological list of agents tried, durations, dates, and documented outcomes or reasons for change
• Clinical severity documentation: prescriber's narrative of disease burden and functional impact
• Prescriber medical-necessity letter: the cornerstone of the appeal; should address each Cigna criterion line-by-line with specific chart citations
• Applicable guideline reference: the prescriber should cite the relevant ADA, AACE/ACE, or Obesity Medicine Association guideline to support the clinical decision

## Criteria-Mapping Structure

Create a table with three columns: (1) Cigna's requirement (quoted from the policy); (2) the chart fact satisfying it; (3) the source document and date. Submit this table as a cover attachment. Medical directors reviewing appeals respond to clear criterion-by-criterion documentation far more reliably than narrative letters alone. Every requirement must be answered — leave none blank.